Literature DB >> 27638743

Nuclear imaging of cardiac amyloidosis. 'We've only just begun'.

Pradeep Bhambhvani1, Fadi G Hage2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27638743     DOI: 10.1007/s12350-016-0661-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  18 in total

1.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.

Authors:  Dean A Fergusson; Paul C Hébert; C David Mazer; Stephen Fremes; Charles MacAdams; John M Murkin; Kevin Teoh; Peter C Duke; Ramiro Arellano; Morris A Blajchman; Jean S Bussières; Dany Côté; Jacek Karski; Raymond Martineau; James A Robblee; Marc Rodger; George Wells; Jennifer Clinch; Roanda Pretorius
Journal:  N Engl J Med       Date:  2008-05-14       Impact factor: 91.245

2.  Accurate analysis and visualization of cardiac (11)C-PIB uptake in amyloidosis with semiautomatic software.

Authors:  Tanja Kero; Lars Lindsjö; Jens Sörensen; Mark Lubberink
Journal:  J Nucl Cardiol       Date:  2015-07-15       Impact factor: 5.952

3.  Cardiac amyloidosis: a treatable disease, often overlooked.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2011-08-30       Impact factor: 29.690

4.  Quantitative molecular imaging of cardiac amyloidosis: The journey has begun.

Authors:  Sharmila Dorbala; Marie Foley Kijewski; Mi-Ae Park
Journal:  J Nucl Cardiol       Date:  2015-07-16       Impact factor: 5.952

5.  Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.

Authors:  Claudio Rapezzi; Candida C Quarta; Pier Luigi Guidalotti; Cinzia Pettinato; Stefano Fanti; Ornella Leone; Alessandra Ferlini; Simone Longhi; Massimiliano Lorenzini; Letizia Bacchi Reggiani; Christian Gagliardi; Pamela Gallo; Caterina Villani; Fabrizio Salvi
Journal:  JACC Cardiovasc Imaging       Date:  2011-06

6.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Authors:  Enrica Perugini; Pier Luigi Guidalotti; Fabrizio Salvi; Robin M T Cooke; Cinzia Pettinato; Letizia Riva; Ornella Leone; Mohsen Farsad; Paolo Ciliberti; Letizia Bacchi-Reggiani; Francesco Fallani; Angelo Branzi; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

7.  Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.

Authors:  S Janssen; D A Piers; M H van Rijswijk; S Meijer; E Mandema
Journal:  Eur J Nucl Med       Date:  1990

8.  11C-Pittsburgh B PET imaging in cardiac amyloidosis.

Authors:  Seung-Pyo Lee; Eun Seong Lee; Hongyoon Choi; Hyung-Jun Im; Youngil Koh; Min-Ho Lee; Ji-Hyun Kwon; Jin Chul Paeng; Hyung-Kwan Kim; Gi Jeong Cheon; Yong-Jin Kim; Inho Kim; Sung-Soo Yoon; Jeong-Wook Seo; Dae-Won Sohn
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-04

9.  Evaluation of myocardial uptake of 99mtechnetium pyrophosphate in clinical exercise-induced ventricular ischemia.

Authors:  D S Berman; A F Salel; E A Amsterdam; G L DeNardo; D T Mason
Journal:  Chest       Date:  1977-03       Impact factor: 9.410

10.  A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir.

Authors:  Dustin R Osborne; Shelley N Acuff; Alan Stuckey; Jonathan S Wall
Journal:  Front Cardiovasc Med       Date:  2015-05-08
View more
  1 in total

1.  Significance of 11C-PIB PET/CT in cardiac amyloidosis compared with 99mTc-aprotinin scintigraphy: A pilot study.

Authors:  Ryogo Minamimoto; Toru Awaya; Kentaro Iwama; Masatoshi Hotta; Kazuhiko Nakajima; Risen Hirai; Osamu Okazaki; Yukio Hiroi
Journal:  J Nucl Cardiol       Date:  2018-03-27       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.